MiniMed Group financials
$19.29+2.33%
Close Nov 4, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Apr 30 |
|---|---|
| Revenue | $3.10B |
| Gross profit | $1.68B |
| Gross margin | 54.2% |
| Operating income | -$190.0M |
| Net income | -$333.0M |
| Net margin | −10.7% |
| Diluted EPS | $-1.30 |
| EBITDA | -$172.0M |
| Operating cash flow | — |
| Free cash flow | — |
| Diluted shares | 256.6M |
Balance sheet
| Period end | Apr 24 |
|---|---|
| Cash & equivalents | $298.0M |
| Short-term investments | $0.00 |
| Total debt | $0.00 |
| Total assets | $4.63B |
| Total liabilities | $1.02B |
| Shareholders' equity | $3.61B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology